Literature DB >> 15625204

Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.

Warrick J Brewer1, Shona M Francey, Stephen J Wood, Henry J Jackson, Christos Pantelis, Lisa J Phillips, Alison R Yung, Vicki A Anderson, Patrick D McGorry.   

Abstract

OBJECTIVE: While cognitive deficits are frequently reported in psychotic disorders, it is unclear whether these impairments predate the onset of illness and to what extent they are predictive of later transition to psychosis.
METHOD: The authors studied 37 healthy volunteers and 98 symptomatic, help-seeking patients meeting the inclusion criteria of a treatment program for people at ultra-high risk for psychosis. Of the ultra-high-risk patients, 34 (34.7%) developed psychosis over the course of the investigation. Premorbid and current IQ, attention, memory, and executive functioning were measured with instruments including subtests from the Wechsler Memory Scale-Revised (WMS-R). Analyses compared the ultra-high-risk patients who became psychotic, those who did not become psychotic, and the comparison subjects.
RESULTS: Overall, the ultra-high-risk subjects had significantly lower performance IQs than the comparison subjects. Further, impairments were also found in the visual reproduction subtest and the verbal memory index (predominantly owing to lower logical memory scores) of the WMS-R that were specific to the ultra-high-risk-patients who developed psychosis. No other memory, attentional, or executive tasks discriminated between any of the groups.
CONCLUSIONS: These findings suggest that visuospatial processing impairment and some memory deficits were apparent before the full expression of psychotic illness. Cognitive performance on more complex tasks requiring rapid registration and efficient recall may be compromised before development of first-episode psychosis. Further experimental tasks that challenge these cognitive domains are required to clarify the predictive value of these results.

Entities:  

Mesh:

Year:  2005        PMID: 15625204     DOI: 10.1176/appi.ajp.162.1.71

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  106 in total

1.  Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Authors:  Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Parcellations and hemispheric asymmetries of human cerebral cortex analyzed on surface-based atlases.

Authors:  David C Van Essen; Matthew F Glasser; Donna L Dierker; John Harwell; Timothy Coalson
Journal:  Cereb Cortex       Date:  2011-11-02       Impact factor: 5.357

Review 3.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 4.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

Review 5.  Assessment of adolescents at risk for psychosis.

Authors:  Karin Borgmann-Winter; Monica E Calkins; Kathryn Kniele; Raquel E Gur
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

6.  MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults.

Authors:  George C Nitzburg; Pamela Derosse; Katherine E Burdick; Bart D Peters; Chaya B Gopin; Anil K Malhotra
Journal:  Schizophr Res       Date:  2013-12-08       Impact factor: 4.939

Review 7.  Biomarkers in psychosis: an approach to early identification and individualized treatment.

Authors:  Heline Mirzakhanian; Fiza Singh; Kristin S Cadenhead
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

8.  Should cognitive impairment be included in the diagnostic criteria for schizophrenia?

Authors:  Richard S E Keefe
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

9.  Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable?

Authors:  David Kimhy; Kelly Durbin; Cheryl M Corcoran
Journal:  Prim psychiatry       Date:  2009

10.  Neurodevelopmental Genomic Strategies in the Study of the Psychosis Spectrum.

Authors:  Raquel E Gur
Journal:  Nebr Symp Motiv       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.